Literature DB >> 14966386

Growth hormone and IGF-1.

Roberto Salvatori1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14966386     DOI： 10.1023/B:REMD.0000016121.58762.6d

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  58 in total

1.  Biologically inactive growth hormone caused by an amino acid substitution.

Authors:  Y Takahashi; H Shirono; O Arisaka; K Takahashi; T Yagi; J Koga; H Kaji; Y Okimura; H Abe; T Tanaka; K Chihara
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Endocrine function and morphological findings in patients with disorders of the hypothalamo-pituitary area: a study with magnetic resonance.

Authors:  E Cacciari; S Zucchini; G Carlà; P Pirazzoli; A Cicognani; M Mandini; M Busacca; C Trevisan
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

3.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  A dominant-negative mutation of the growth hormone receptor causes familial short stature.

Authors:  R M Ayling; R Ross; P Towner; S Von Laue; J Finidori; S Moutoussamy; C R Buchanan; P E Clayton; M R Norman
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

5.  Three new mutations in the gene for the growth hormone (gh)-releasing hormone receptor in familial isolated gh deficiency type ib.

Authors:  R Salvatori; X Fan; J A Phillips; R Espigares-Martin; I Martin De Lara; K L Freeman; L Plotnick; A Al-Ashwal; M A Levine
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

6.  Brief report: short stature caused by a mutant growth hormone.

Authors:  Y Takahashi; H Kaji; Y Okimura; K Goji; H Abe; K Chihara
Journal:  N Engl J Med       Date:  1996-02-15       Impact factor: 91.245

7.  Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse.

Authors:  M P Wajnrajch; J M Gertner; M D Harbison; S C Chua; R L Leibel
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

8.  Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.

Authors:  P Q Thomas; M T Dattani; J M Brickman; D McNay; G Warne; M Zacharin; F Cameron; J Hurst; K Woods; D Dunger; R Stanhope; S Forrest; I C Robinson; R S Beddington
Journal:  Hum Mol Genet       Date:  2001-01-01       Impact factor: 6.150

9.  Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia.

Authors:  José Augusto Soares Barreto-Filho; Marta Regina S Alcântara; Roberto Salvatori; Martha Azevedo Barreto; Antônio Carlos Sobral Sousa; Valquíria Bastos; Anita Hermínia Souza; Rossana Maria C Pereira; Peter E Clayton; Matthew S Gill; Manuel Hermínio Aguiar-Oliveira
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

10.  Magnetic resonance imaging study of pituitary morphology in subjects homozygous and heterozygous for a null mutation of the GHRH receptor gene.

Authors:  Helio A Oliveira; Roberto Salvatori; Miriam P O Krauss; Carla R P Oliveira; Paula R C Silva; Manuel H Aguiar-Oliveira
Journal:  Eur J Endocrinol       Date:  2003-04       Impact factor: 6.664
View more
  6 in total

1.  FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.

Authors:  Joo Young Huh; Grigorios Panagiotou; Vassilis Mougios; Mary Brinkoetter; Maria T Vamvini; Benjamin E Schneider; Christos S Mantzoros
Journal:  Metabolism       Date:  2012-09-25       Impact factor: 8.694

2.  Mutation analysis of the muscarinic cholinergic receptor genes in isolated growth hormone deficiency type IB.

Authors:  Ali Mohamadi; Marco Martari; Cindy D Holladay; John A Phillips; Primus E Mullis; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2009-05-05       Impact factor: 5.958

Review 3.  Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.

Authors:  María Teresa Arias-Loste; Isidora Ranchal; Manuel Romero-Gómez; Javier Crespo
Journal:  Int J Mol Sci       Date:  2014-12-12       Impact factor: 5.923

4.  Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.

Authors:  Ling Hou; Zhi-Hang Chen; Dong Liu; Yuan-Guo Cheng; Xiao-Ping Luo
Journal:  Drug Des Devel Ther       Date:  2015-12-18       Impact factor: 4.162

5.  Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial.

Authors:  Chengjun Sun; Biao Lu; Yu Liu; Yaqin Zhang; Haiyan Wei; Xu Hu; Pei Hu; Qian Zhao; Yanling Liu; Kan Ye; Kan Wang; Zaiyan Gu; Zheng Liu; Jin Ye; Hongxiao Zhang; Hong Zhu; Zhihong Jiang; Yanjie Liu; Naijun Wan; Chengming Yan; Jianying Yin; Lirong Ying; Feng Huang; Qingjin Yin; Li Xi; Feihong Luo; Ruoqian Cheng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-25       Impact factor: 5.555

6.  PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins.

Authors:  Martin Schlapschy; Uli Binder; Claudia Börger; Ina Theobald; Klaus Wachinger; Sigrid Kisling; Dirk Haller; Arne Skerra
Journal:  Protein Eng Des Sel       Date:  2013-06-10       Impact factor: 1.650
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.